Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2016
At a glance
- Drugs DFD 05 (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 01 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2016.
- 21 Jun 2016 New trial record